LatchBio
San Francisco, California, United States
The convergence of laboratory automation, high-throughput assays, and machine learning is moving the medium of biological discovery to silicon. Bench top experimentation will be the machine code of the biological programmer, simple instructions that are executed by robotics just as bytes are fed through a compiler. However, if the goal of creating arbitrary synthetic life is to be realized, we need to upgrade our tooling. We will need robust software that operates at the abstraction level of the organism. We will need a programming language that speaks fluently with DNA, RNA, and amino acids as native primitives. We have attempted to adapt the tooling of classical computing towards the biological domain without teaching the computer about biology. We wonder why we haven't cured cancer or reproduced Jurassic Park, meanwhile our DNA sits in computer memory as static bytecode.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.latch.bio
Only accessible to MedStartr community members.
Join nowWhat do you think of LatchBio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now